Jounce Therapeutics, Inc. Operating Income 2017-2022 | JNCE
Jounce Therapeutics, Inc. operating income from 2017 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Jounce Therapeutics, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2022 | $-52 |
| 2021 | $-91 |
| 2020 | $-45 |
| 2019 | $53 |
| 2018 | $-31 |
| 2017 | $-19 |
| 2016 | $-14 |
| 2015 | $-30 |
| 2014 | $-16 |
| Jounce Therapeutics, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2022-12-31 | $-32 |
| 2022-09-30 | $-31 |
| 2022-06-30 | $-34 |
| 2022-03-31 | $-37 |
| 2021-12-31 | $-30 |
| 2021-09-30 | $-30 |
| 2021-06-30 | $-4 |
| 2021-03-31 | $-27 |
| 2020-12-31 | $-27 |
| 2020-09-30 | $-25 |
| 2020-06-30 | $-28 |
| 2020-03-31 | $-27 |
| 2019-12-31 | $-24 |
| 2019-09-30 | $98 |
| 2019-06-30 | $-8 |
| 2019-03-31 | $-13 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-9 |
| 2018-06-30 | $-6 |
| 2018-03-31 | $-14 |
| 2017-12-31 | $-12 |
| 2017-09-30 | $-4 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $-0 |
| 2016-12-31 | $5 |
| 2016-09-30 | $4 |
| 2016-06-30 | $-12 |
| 2016-03-31 | $-11 |
